1887
Volume 2011, Issue 2
  • ISSN: 0253-8253
  • EISSN: 2227-0426

Abstract

The diagnosis of growth hormone deficiency (GHD) needs consideration of both clinical and biological aspects such as auxological data, GH provocative tests and active metabolites of GH including IGF-I and IGFBP-3. In children with GHD, recombinant human GH (rhGH) replacement therapy has been used worldwide with minimal serious side effects. This study aimed to report the results of an investigations for GHD, to describe the growth responses to rhGH in deficient children compared to those without GH deficiency, to evaluate the relationship between clinical and biochemical responses, and to describe the experience of diagnosis and treatment with rhGH at Hamad General Hospital, the main hospital in Qatar where most short children are referred for further investigation. The clinical records of 116 short children were reviewed retrospectively. Forty-six failed the clonidine test and 42 of these also failed the glucagon test and were confirmed with GHD. These and 16 children without GDH were treated with rhGH (25 gg/kg/ day) and were evaluated in terms of growth response, HtSDS, changes of IGF-I concentration and the relationship between these parameters. Treatment with GH of short children with GHD does produce a satisfactory growth response but the HtSDS gain was significantly higher in those with GHD compared to children without GHD. Measurement of IGF-I was found not to be a useful diagnostic test in GHD.

Loading

Article metrics loading...

/content/journals/10.5339/qmj.2011.2.13
2011-12-01
2024-04-19
Loading full text...

Full text loading...

References

  1. Angsusingha K, Watcharasindhu S, Likitmaskul S, Tuchinda C. Growth hormone therapy update in Thailand. Horm Res. 1998; 49:Suppl 1:1520.
    [Google Scholar]
  2. Aroonparkmonkol S, Wacharasindhu S, Srivuthana S. Serum IGF-I and IGFBP-3 level by ELISA in normal and growth hormone deficient children. Chula Med J. 2001; 45::215222.
    [Google Scholar]
  3. National Center for Health Statistics. NCHS growth curves for children: birth-18years, United States. DHEW Publication No. (PHS) 78-1650. Hyattsville, MD: U.S. Department of Health, Education, and Welfare Public Health Service National Center for Health Statistics 1977.
    [Google Scholar]
  4. Bright GM, Julius JR, Lima J, Blethen SL. Growth hormone stimulation test results as predictors of recombinant human growth hormone treatment outcomes: preliminary analysis of the national cooperative growth study database. Pediatrics. 1999; 104::10281031.
    [Google Scholar]
  5. Badaru A, Wilson DM. Alternatives to growth hormone stimulation testing in children. Trends Endocrinol Metab. 2004; 15::252258.
    [Google Scholar]
  6. Coutant R, Rouleau S, Despert F, Magontier N, Loisel D, Lima IJM. Growth and adult height in GH-treated children with nonacquired GH deficiency and idiopathic short stature: The influence of pituitary magnetic resonance imaging findings. J Clin Endocrinol Metab. 2001; 86::46494654.
    [Google Scholar]
  7. Juul A, Skakkebaek NE. Prediction of the outcome of growth hormone provocative testing in short children by measurement of serum levels of insulin like growth factor I and insulin-like growth factor binding protein 3. J Pediatr. 1997; 130::197204.
    [Google Scholar]
  8. Cohen P, Bright GM, Rogol AD, Kappelgaard AM, Rosenfeld RG. Effects of dose and gender on the growth and growth factor response to GH in GHdeficient children: implications for efficacy and safety. J Clin Endocrinol Metab. 2002; 87::9098.
    [Google Scholar]
  9. Saggese G, Ranke MB, Saenger P, Rosenfeld RG, Tanaka T, Chaussain JL, et al., Diagnosis and treatment of growth hormone deficiency in children and adolescents: towards a consensus. Ten years after the Availability of Recombinant Human Growth Hormone Workshop held in Pisa, Italy; 27-28 March 1998. Horm Res. 1998; 50::320340.
    [Google Scholar]
  10. Hintz RL, Attie KM, Baptista J, Roche A. Effect of growth hormone treatment on adult height of children with idiopathic short stature. Genentech Collaborative Group. N Engl J Med. 1999; 340::502507.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/qmj.2011.2.13
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error